首页 | 本学科首页   官方微博 | 高级检索  
   检索      


A study of inhibitors of d-glycero-β-d-manno-heptose-1-phosphate adenylyltransferase from Burkholderia pseudomallei as a potential antibiotic target
Authors:Suwon Kim  Seri Jo  Mi-Sun Kim  Dong Hae Shin
Institution:College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha W. University, Seoul, Republic of Korea
Abstract:d-Glycero-β-d-manno-heptose-1-phosphate adenylyltransferase from Burkholderia pseudomallei (BpHldC) is the fourth enzyme in the ADP‐lglycero‐β‐dmanno‐heptose biosynthesis pathway producing a lipopolysaccharide core. Therefore, BpHldC is an anti-melioidosis target. Three ChemBridge compounds purchased from ChemBridge Corporation (San Diego, CA) were found to have an effective inhibitory activity on BpHldC. Interestingly, ChemBridge 7929959 was the most effective compound due to the presence of the terminal benzyl group. The enzyme kinetic study revealed that most of them show mixed type inhibitory modes against ATP and βG1P. The induced-fit docking indicated that the medium affinity of ChemBridge 7929959 is originated from its benzyl group occupying the substrate-binding pocket of BpHldC. The inhibitory role of terminal aromatic groups was proven with ChemBridge 7570508. Combined with the previous study, ChemBridge 7929959 is found to work as a dual inhibitor against both HldC and HddC. Therefore, three ChemBridge compounds can be developed as a potent anti-melioidosis agent with a novel inhibitory concept.
Keywords:d-Glycero-β  -d-manno-heptose-1-phosphate adenylyltransferase  Burkholderia pseudomallei  ADP‐  l‐  glycero‐  β    d‐  manno‐  heptose  ChemBridge compounds  anti-melioidosis agent
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号